about
sameAs
Radical prostatectomy versus watchful waiting for prostate cancerWatchful waiting versus prostatectomy for prostate cancerRisk stratification and early oncologic outcomes following robotic prostatectomyThe role of SPINK1 in ETS rearrangement-negative prostate cancersOutcomes of localized prostate cancer following conservative managementProstate mechanical imaging: 3-D image composition and feature calculationsSaudi oncology society and Saudi urology association combined clinical management guidelines for prostate cancerProstate-Specific Antigen (PSA)-Based Population Screening for Prostate Cancer: An Evidence-Based AnalysisPotential Utility of Novel Biomarkers in Active Surveillance of Low-Risk Prostate CancerLifestyle and dietary factors in the prevention of lethal prostate cancerRandomised prostate cancer screening trial: 20 year follow-upMolecular biomarker analyses using circulating tumor cellsEntry effects of droplet in a micro confinement: Implications for deformation-based circulating tumor cell microfiltrationCellular signaling by fibroblast growth factors (FGFs) and their receptors (FGFRs) in male reproduction.Traditional Indian medicine and homeopathy for HIV/AIDS: a review of the literature.Molecular sampling of prostate cancer: a dilemma for predicting disease progression.Plasma levels of acid-labile subunit, free insulin-like growth factor-I, and prostate cancer risk: a prospective study.Image guidance for focal therapy of prostate cancer.Results of a Randomized Clinical Trial of the Action of Several Doses of Lycopene in Localized Prostate Cancer: Administration Prior to Radical Prostatectomy.Predicting 15-year prostate cancer specific mortality after radical prostatectomy.Evolution from active surveillance to focal therapy in the management of prostate cancer.Increased risk of high-grade prostate cancer among infertile men.Development of a new method for monitoring prostate-specific antigen changes in men with localised prostate cancer: a comparison of observational cohorts.Critical review of prostate cancer predictive toolsTargeting monoamine oxidase A in advanced prostate cancer.Novel therapies for metastatic castrate-resistant prostate cancer.Prostate-cancer mortality at 11 years of follow-up.Metabolic imaging of patients with prostate cancer using hyperpolarized [1-¹³C]pyruvateImpact of immediate TRUS rebiopsy in a patient cohort considering active surveillance for favorable risk prostate cancer.Identification of a novel prostate cancer biomarker, caveolin-1: Implications and potential clinical benefit.Patient perspective on watchful waiting/active surveillance for localized prostate cancer.Vicious cycle of TGF-β signaling in tumor progression and metastasis.Multidisciplinary Versus One-on-One Setting: A Qualitative Study of Clinicians' Perceptions of Their Relationship With Patients With Prostate CancerPhospho-Akt immunoreactivity in prostate cancer: relationship to disease severity and outcome, Ki67 and phosphorylated EGFR expressionA multi-institutional evaluation of active surveillance for low risk prostate cancer.What if I don't treat my PSA-detected prostate cancer? Answers from three natural history models.mRNA expression signature of Gleason grade predicts lethal prostate cancerIdentification and validation of potential new biomarkers for prostate cancer diagnosis and prognosis using 2D-DIGE and MS.An update on TroVax for the treatment of progressive castration-resistant prostate cancerCombining urinary detection of TMPRSS2:ERG and PCA3 with serum PSA to predict diagnosis of prostate cancer.
P2860
Q24236564-1DAD2716-F76F-4524-8BEB-AC64F558BC51Q24244913-9E9002C7-618D-4ECA-AF65-088E5E24B25CQ24632732-569888E7-66F5-42E1-87B7-3E47CA86829FQ24647020-EEA13A64-0006-4C05-AB05-27B6FEE0E291Q24647380-BFAAB207-8021-4D23-B282-FCED7010F6CBQ24648642-8A36394D-22DE-4288-B83B-EFBA1C71E75BQ26747782-F469FA88-D731-452B-8387-521219826725Q26781093-090C5EB8-2826-4F41-B086-C1ED79D49857Q26784517-FC3B5A67-CD53-4730-9123-AF8EB4F4AB19Q27025735-6D694B69-2DA1-44FB-B33F-1BFF3C854420Q28741447-B6EDD56A-EC5A-4CC4-BD69-E4B9B1DC8AA5Q28749394-0816EF61-CCBC-400E-90F5-EEC62DB14D6AQ30387411-8AF7B967-BB33-4ABA-A8A9-AD0982ADD8DEQ30439922-19000239-29F6-4553-8863-1B359F94186DQ30485862-473CAA61-EC6B-43ED-BB90-5B7118CE6F50Q33541296-E1E745E9-1A62-4A73-9507-89BAE21DA36BQ33645688-E92ECB04-38C7-4248-8836-B4A8C173CCFDQ33724312-1F4578E5-D2B0-4C73-8413-B5EDBD529783Q33757794-CF1A6A42-9244-47C5-B068-48CCC6713D19Q33759725-77376949-1602-4345-892D-0DE4B5353420Q33933490-4A664E9B-292E-45C8-BDCE-ECE598CFB251Q33948103-C7A0B4D8-8CC5-4A38-9AB2-C73F82F3C41FQ34021773-1DD751AF-355B-4653-BF3C-AC51338187F4Q34104562-CAE8DFC5-0C29-43AE-AF9D-2F15F9F6C98AQ34154664-70ECCFD9-473E-441A-A803-896DDC9A5B7BQ34249263-02E38C81-381D-4539-A5C9-00E1ACB1DE76Q34261229-4E49EDD1-AB20-4DE1-A9B4-6C078CF699D3Q34359533-8533B74E-8F1D-402C-81BE-590844E2F69BQ34406115-A8C73968-E5CB-4E0C-8A57-5CA550944C24Q34417941-01766F51-127E-489F-82A6-D1EA2005D56AQ34419421-43CEB78E-78CD-41AC-9D96-3A3F1D8A4760Q34448186-FEE8F1B6-026C-4FD6-8008-7B7484639EA0Q34459761-1A786A74-C8D8-4008-AE09-0C26170ABCF7Q34469245-F256322D-EB7F-47DE-A7E5-FA90F7883E8FQ34541484-471E1919-9BED-486F-9728-370276250520Q34963971-0C202C03-2D73-4E9C-AADB-5DEFCBECF04DQ35023464-5B8E1D72-51E8-47B2-9EAB-B7A917C21731Q35033878-B753EE8A-552A-4212-8717-93E0C8652CEEQ35050205-D441D5AF-5C89-4639-B8AB-4DDFC4E979BFQ35535776-46FC9F6B-FC49-46F2-AD68-5414BADBCAE5
P2860
description
article publié dans la revue scientifique Journal of the American Medical Association
@fr
im Juni 2004 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published in The Journal of the American Medical Association
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в червні 2004
@uk
name
Natural History of Early, Localized Prostate Cancer
@en
Natural History of Early, Localized Prostate Cancer
@nl
type
label
Natural History of Early, Localized Prostate Cancer
@en
Natural History of Early, Localized Prostate Cancer
@nl
altLabel
Natural history of early, localized prostate cancer
@en
Natural history of early, localized prostate cancer
@nl
prefLabel
Natural History of Early, Localized Prostate Cancer
@en
Natural History of Early, Localized Prostate Cancer
@nl
P2093
P50
P356
P1476
Natural History of Early, Localized Prostate Cancer
@en
Natural history of early, localized prostate cancer
@en
P2093
Anders Magnuson
Jan-Erik Johansson
Ove Andrén
Swen-Olof Andersson
P356
10.1001/JAMA.291.22.2713
P407
P577
2004-06-09T00:00:00Z